Invicta Diagnostic's IPO debuted strongly on December 8, listing at ₹100, a 17.65% premium over its issue price of ₹85. The ...
Capital Market on MSN
NSE SME Invicta Diagnostic starts with a healthy lift
The stock listed at Rs 100, a 17.65% premium to the IPO price, and is currently frozen at its lower limit of 5% over the ...
The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...
Invicta Diagnostic is set to debut on the NSE SME platform on December 8, following a successful IPO that raised 28.12 crore.
You know, healthcare is changing so fast, and a lot of that has to do with computers getting smarter. We’re talking about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback